Rigel Pharmaceuticals Inc (RIGL)
1.47
-0.02
(-1.34%)
USD |
NASDAQ |
Mar 28, 16:00
1.47
0.00 (0.00%)
Pre-Market: 20:00
Rigel Pharmaceuticals Total Long Term Debt (Quarterly): 59.60M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 59.60M |
September 30, 2023 | 59.66M |
June 30, 2023 | 59.57M |
March 31, 2023 | 59.48M |
December 31, 2022 | 39.45M |
September 30, 2022 | 39.47M |
June 30, 2022 | 29.84M |
March 31, 2022 | 29.85M |
December 31, 2021 | 19.91M |
September 30, 2021 | 19.89M |
June 30, 2021 | 19.86M |
March 31, 2021 | 19.84M |
December 31, 2020 | 19.82M |
September 30, 2020 | 19.84M |
June 30, 2020 | 19.82M |
March 31, 2020 | 9.829M |
December 31, 2019 | 9.81M |
September 30, 2019 | 9.789M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2019
59.66M
Maximum
Sep 2023
27.27M
Average
19.87M
Median
Total Long Term Debt (Quarterly) Benchmarks
Corcept Therapeutics Inc | 0.00 |
Nektar Therapeutics | 0.00 |
Avid Bioservices Inc | 141.15M |
Stereotaxis Inc | 0.00 |
Puma Biotechnology Inc | 99.66M |